Organisation paid for research Program year 2025 Source: CMS Open Payments

Accellacare DuPage

Neither a doctor nor a teaching hospital

Research payments

$6,499

9 payments

Through program year 2025, Accellacare DuPage is reported as receiving $6,499 in research payments, across 9 payments.

By program year

4 rows

Year	Kind	Amount	Payments
2025	Research	$3,413	1
2024	Research	$2,074	1
2023	Research	$808	2
2022	Research	$205	5

Breakdown

Who paid Research payments · program years 2022–2025

Pfizer Inc. $6,499 9 payments

Studies the money was for Research payments · program years 2022–2025

A Phase 3 Study to Evaluate the Safety Tolerability and Immunogenicity of A Respiratory Syncytial Virus RSV Prefusion F Subunit Vaccine in Adults 60 Years of Age and Older $3,413 1 payment
A Phase 3 Study to Evaluate the Efficacy Immunogenicity and Safety of Respiratory Syncytial Virus RSV Prefusion F Subunit Vaccine in Adults $2,074 1 payment
A Phase 3 Randomized Observerblinded Study to Evaluate the Safety Tolerability and Immunogenicity of A Combined Modified Rna Vaccine Candidate Against Covid19 and Influenza in Healthy Individuals $404 1 payment
A Phase 3 Randomized Observerblinded Study to Evaluate the Efficacy Safety Tolerability and Immunogenicity of A Modified Rna Vaccine Against Influenza Compared to Licensed Inactivated Influenza Vaccine in Healthy Adults 18 Years of Age Or Older $404 1 payment
A Phase 3 Randomized Observerblinded Study to Evaluate the Efficacy Safety Tolerability and Immunogenicity of A Modified Rna Vaccine Against Influenza Compared to Licensed Inactivated Influenza Vaccine in Healthy Adults 18 Years of Age Or Older $205 5 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.